Ex Parte Dolnik et al - Page 4



             Appeal No.  2005-1918                                                              Παγε 4               
             Application No. 09/946,396                                                                              
             resulting from the sensitivity limitations of the method used in Gebert[ ] for determining              
             protein content” (id.).  Appellants submit the declaration of co-inventor William A.                    
             Gurske (dated August 13, 2003) in support of their assertions that “the method of                       
             Gebert cannot produce or measure the purity of galactomannan disclosed in portions of                   
             the Gebert [patent]” (Brief, page 9).  Having carefully considered the declaration, we find             
             insufficient basis to support appellants’ assertions.                                                   
                    The basis of Dr. Gurske’s conclusion that Gebert’s purified preparation must                     
             have contained at least 0.40 % protein, rather than the values reported at column 15,                   
             Table 4, is essentially as follows: “Gebert purified galactomannans by centrifugation and               
             ethanol precipitation” (Declaration, page 4), and this method “is known from prior art                  
             literature”3 which “demonstrate[s] that the methods disclosed in Gebert cannot produce                  
                                                                                                                    
                    3 The following references were attached to the Declaration of William A. Gurske,                
             in support of the conclusions therein:                                                                  
             Heyne & Whistler (Reference “P”), “Chemical Composition and Properties of Guar                          





















Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007